Search results
Merck's (MRK) Lung Cancer Candidate Faces FDA Rejection
Zacks via Yahoo Finance UK· 4 days agoThe FDA's CRL to Merck (MRK) and its partner Daiichi Sankyo for the patritumab deruxtecan BLA is...
FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
Zacks via Yahoo Finance UK· 5 days agoThe FDA grants priority review to Ionis' (IONS) filing seeking approval for olezarsen to treat...
3 Healthcare Mutual Funds Thriving Amid Economic Shifts
Zacks via Yahoo Finance UK· 5 days agoHealthcare mutual funds such as FPHAX, VGHCX and PHSTX are increasingly favored as solid investments...
MARKET REPORT: Nvidia shares recover after $577bn sell-off
This Is Money· 6 days agoShares in artificial intelligence chip designer Nvidia rose nearly 6 per cent after a three-day rout...
Nearly £5bn wiped off value of GSK as US restricts RSV vaccine jabs
This Is Money· 4 days agoNearly £5billion was wiped off the value of GSK after a top US health agency limited the scope of its blockbuster respiratory vaccine. In a further setback for the UK pharmaceutical giant, the ...
Astra’s RSV Shot for Babies Likely Too Pricey For UK’s NHS
Bloomberg· 6 days agoThe UK’s decision not to provide babies with a shot against RSV is likely driven in part by cost...
London close: Stocks mixed ahead of key UK, US data
ShareCast· 4 days agoLondon stocks ended Thursday's trading session with a mixed performance as market participants awaited crucial US inflation data and UK GDP figures set...
Far-right win leaves France amid shock and chaos
Reuters· 19 hours agoFrance is fast heading towards a year of political, economic and maybe financial chaos. After the first round of parliamentary elections on Sunday, the prospect of a far-right government commanding ...
3 FTSE 100 bargains I’d love to add to my Stocks and Shares ISA in July
Motley Fool UK· 1 day agoLuxury goods brand Burberry Group (LSE: BRBY) was the second-worst performer on the entire FTSE 100...
US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug
Reuters· 4 days ago, opens new tab lung cancer treatment, which belongs to a lucrative class of cancer therapies that work like "guided missiles". The FDA cited findings from an inspection of a third-party manufacturing ...